Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Four months after being taken private by private equity firms, Albany Molecular Research Inc. (AMRI) announced that Michael Mulhern will replace William S. Marth as CEO. Mulhern was previously CEO of Sterigenics International, a specialist in sterilization, gamma technologies, and medical isotopes owned by GTCR, the investment firm that acquired AMRI in partnership with the Carlyle Group. Marth, who replaced the company’s founder, Tom D’Ambra, in 2013, will remain with the company in an advisory role, according to AMRI.
This article has been sent to the following recipient: